Epigenetic silencing of triple negative breast cancer hallmarks by Withaferin A
2017 · Oncotarget · 68 citations
https://doi.org/10.18632/oncotarget.17107
K
Ken Declerck
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
90
Papers
1.8K
Citations
19
h-index
27
i10-index
Ken Declerck is an academic researcher. The author has contributed to research in topics: Epigenetics and DNA Methylation & Acute Myeloid Leukemia Research & CAR-T cell therapy research. The author has an h-index of 19, co-authored 77 publications.
ORCID: 0000-0001-8104-8054Papers by this author
worksIdentification of differentially methylated BRCA1 and CRISP2 DNA regions as blood surrogate markers for cardiovascular disease
2017 · Scientific Reports · 58 citations
https://doi.org/10.1038/s41598-017-03434-0
Interaction between prenatal pesticide exposure and a common polymorphism in the PON1 gene on DNA methylation in genes associated with cardio-metabolic disease risk—an exploratory study
2017 · Clinical Epigenetics · 39 citations
https://doi.org/10.1186/s13148-017-0336-4
(−)-Epicatechin metabolites promote vascular health through epigenetic reprogramming of endothelial-immune cell signaling and reversing systemic low-grade inflammation
2019 · Biochemical Pharmacology · 39 citations
https://doi.org/10.1016/j.bcp.2019.113699
Flavanol Consumption in Healthy Men Preserves Integrity of Immunological‐Endothelial Barrier Cell Functions: Nutri(epi)genomic Analysis
2022 · Molecular Nutrition & Food Research · 20 citations
https://doi.org/10.1002/mnfr.202100991
Echinacea purpurea (L.) Moench treatment of monocytes promotes tonic interferon signaling, increased innate immunity gene expression and DNA repeat hypermethylated silencing of endogenous retroviral sequences
2021 · BMC Complementary Medicine and Therapies · 18 citations
https://doi.org/10.1186/s12906-021-03310-5
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat